PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹265 Cr | ₹271 Cr | ₹85 Cr | ₹960 Cr | ₹741 Cr |
What is the latest Total Non-Current Liabilities ratio of PANACEA BIOTEC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹265 Cr |
Mar2023 | ₹271 Cr |
Mar2022 | ₹85 Cr |
Mar2021 | ₹960 Cr |
Mar2020 | ₹741 Cr |
How is Total Non-Current Liabilities of PANACEA BIOTEC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹265 Cr | -2.07 | |
Mar2023 | ₹271 Cr | 218.11 | |
Mar2022 | ₹85 Cr | -91.14 | |
Mar2021 | ₹960 Cr | 29.61 | |
Mar2020 | ₹741 Cr | - |
Compare Total Non-Current Liabilities of peers of PANACEA BIOTEC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PANACEA BIOTEC | ₹2,456.0 Cr | -0.8% | -4.1% | 183.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
PANACEA BIOTEC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PANACEA BIOTEC | -0.8% |
-4.1% |
183.6% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses